(iii) induce the synthesis of glutathione, increasing the availability of cysteine and avoiding cell membrane peroxidation [87]
Meanwhile, correlations between the intake and circulating levels of AAs were absent or at most modest (r = 0.005 ~ 0.22, Supplementary Table 3), suggesting that circulating AA levels are not valid markers of AA intake
The incretin, GIP is anticipated to interact with GLP-1 additively
A 2026 preclinical study found behavioral and hippocampal changes in animal models, raising interest in cognitive effects
FDA approval for its once-daily oral semaglutide (Wegovy) tablet, becoming the first oral GLP-1 receptor agonist approved for chronic weight management in adults with obesity or overweight conditions
Molecular basis of enhanced GLP-1 signaling mediated by GLP-1(936) in conjunction with LSN3318839